Lacosamide Tablet, Film Coated
Product Images NDC 58118-8813

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 58118-8813). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Clinical Solutions Wholesale, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lacosamide-fig1 (Lacosamide Fig1)

FDA Label Image

Lacosamide-fig2 (Lacosamide Fig2)

FDA Label Image

Lacosamide 50mg Tablets 30ct Blister Pack (Lacosamide Fig4)

FDA Label Image

Lacosamide 100mg Tablets 30ct Blister Pack (Lacosamide Fig5)

This text provides information about Lacosamide 100mg Tablets, including the NDC (National Drug Code) 58118-8813-8 and quantity of 30 tablets. It also mentions details such as lot number, expiration date, and manufacturer (Camber Pharmaceuticals). The address of the manufacturer is given as Piscataway, New Jersey, USA.*

FDA Label Image

Lacosamide 150mg Tablets 30ct Blister Pack (Lacosamide Fig6)

FDA Label Image

Lacosamide 200mg Tablets 30ct Blister Pack (Lacosamide Fig7)

This text provides information about clinical solutions, specifically Lacosamide 200mg Tablets with NDC 58118-8815-8 and quantity 30. It also mentions a medication with NDC 31722-0815-60, batch number SAMPLE456, manufactured by Camber Pharmaceuticals with an expiration date of March 2027. The location mentioned is Piscataway, NJ, USA. The text also includes coded details related to packaging and distribution.*

FDA Label Image

Lacosamide-logo1 (Lacosamide Logo1)

FDA Label Image

Lacosamide-logo2 (Lacosamide Logo2)

FDA Label Image

Lacosamide-str (Lacosamide Str)

FDA Label Image

Lacosamideosfigure3 (Lacosamideosfigure3)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.